- Home
- PDEX vs KYTX Comparison
PDEX vs KYTX Comparison
Compare PDEX & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDEX
- KYTX
- Stock Information
- Founded
- PDEX 1978
- KYTX 2018
- Country
- PDEX United States
- KYTX United States
- Employees
- PDEX N/A
- KYTX N/A
- Industry
- PDEX Medical/Dental Instruments
- KYTX
- Sector
- PDEX Health Care
- KYTX
- Exchange
- PDEX Nasdaq
- KYTX NYSE
- Market Cap
- PDEX 161.1M
- KYTX 166.4M
- IPO Year
- PDEX N/A
- KYTX 2024
- Fundamental
- Price
- PDEX $44.32
- KYTX $3.34
- Analyst Decision
- PDEX Strong Buy
- KYTX Buy
- Analyst Count
- PDEX 1
- KYTX 5
- Target Price
- PDEX $52.00
- KYTX $23.20
- AVG Volume (30 Days)
- PDEX 24.7K
- KYTX 308.0K
- Earning Date
- PDEX 02-06-2025
- KYTX 02-12-2025
- Dividend Yield
- PDEX N/A
- KYTX N/A
- EPS Growth
- PDEX 1.56
- KYTX N/A
- EPS
- PDEX 1.49
- KYTX N/A
- Revenue
- PDEX $56,798,000.00
- KYTX N/A
- Revenue This Year
- PDEX $15.56
- KYTX N/A
- Revenue Next Year
- PDEX $3.28
- KYTX N/A
- P/E Ratio
- PDEX $29.83
- KYTX N/A
- Revenue Growth
- PDEX 21.01
- KYTX N/A
- 52 Week Low
- PDEX $16.18
- KYTX $3.22
- 52 Week High
- PDEX $59.60
- KYTX $30.60
- Technical
- Relative Strength Index (RSI)
- PDEX 44.43
- KYTX 36.70
- Support Level
- PDEX $45.62
- KYTX $3.24
- Resistance Level
- PDEX $59.60
- KYTX $3.53
- Average True Range (ATR)
- PDEX 3.30
- KYTX 0.28
- MACD
- PDEX -0.73
- KYTX -0.01
- Stochastic Oscillator
- PDEX 5.21
- KYTX 11.54
About PDEX Pro-Dex Inc.
Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.